Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in australian homosexual men

Sexually Transmitted Diseases

Volumn 39, Issue 9, 2012, Pages 726-732

  Poynten, Isobel Mary ^a   Jin, Fengyi ^a,b   Templeton, David J ^a,c   Prestage, Garrett P ^a   Donovan, Basil ^a,d   Pawlita, Michael ^e   Fairley, Christopher K ^f,g   Garland, Suzanne ^h   Grulich, Andrew E ^a   Waterboer, Tim ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d SYDNEY EYE HOSPITAL   (Australia)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANUS INTERCOURSE; ARTICLE; AUSTRALIA; CIRCUMCISION; CONTROLLED STUDY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PAPILLOMAVIRUS INFECTION; RISK FACTOR; SEROLOGY; SEROPOSITIVE REACTION; SEROPREVALENCE; SEXUAL BEHAVIOR;

ADULT; ANUS NEOPLASMS; AUSTRALIA; CIRCUMCISION, MALE; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; MALE; MEN'S HEALTH; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; YOUNG ADULT;

EID: 84865485498     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31825d5cb8     Document Type: Article

References (30)

1. de Sanjose S, Quint W, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11:1048-1056.
2. De Vuyst H, Clifford G, Nascimento M, et al. Prevalence and type distribution of human papillomavirus in carcinoma and in-traepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009; 124:1626-1636.
3. Johnson L, Madeleine M, Newcomer L, et al. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-288.
4. Daling J, Weiss N, Hislop T, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317:973-977.
5. Van Leeuwen M, Vajdic C, Middleton M, et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23: 2183-2190.
6. Australian Institute of Health and Welfare & Australian Association of Cancer Registries 2010; Vol 60: CAN56. Cancer in Australia: an overview 2010. Canberra.
7. Thompson D, Douglas JM, Foster M, et al. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004; 190:1563-1574.
8. Lu B, Hagensee M, Lee J, et al. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev 2010; 19:511-516.
9. Dunne E, Nielson C, Stone K, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-1057.
10. van der Snoek E, Niesters H, Mulder P, et al. Human papilloma-virus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis 2003; 30:639-644.
11. Höpfl R, Petter A, Thaler P, et al. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: A serological study. BMC Infect Dis 2003; 3.
12. Lu B, Viscidi R, Lee J, et al. Human papillomavirus (HPV) 6, 11, 16 and 18 seroprevalence is associated with sexual practice and age: Results from the Multi-National HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev 2011; 20:990-1002.
13. Heiligenberg M, Michael K, Kramer M, et al. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: A population-based study in Amsterdam. Sex Transm Dis 2010; 37:672-680.
14. Hagensee M, Kiviat N, Critchlow C, et al. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 1997; 176:625-631.
15. Stone K, Karem K, Sternberg M, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186:1396-1402.
16. Carter J, Koutsky L, Hughes J, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181:1911-1919.
17. Jin F, Prestage G, Mao L, et al. Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: The Health in Men study. J Infect Dis 2006; 194:561-570.
18. Prestage G, Mao L, Fogarty A, et al. How has the sexual behaviour of gay men changed since the onset of AIDS: 1986-2003. Aust N Z J Public Health 2005; 29:530-535.
19. Waterboer T, Sehr P, Michael K, et al. Multiplex human papil-lomavirus serology based on in situ-purified glutathione S-Trans-ferase Fusion Proteins. Clin Chem 2005; 51:1845-1853.
20. Sehr P, Muller M, Hopfl R, et al. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002; 106:61-70.
21. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: Validation for HPV serology. J Immunol Methods 2001; 254:153-162.
22. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006; 309:200-204.
23. Carter J, Paulson K, Wipf G, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510-1522.
24. Herrero R, Castellsagué X, Pawlita M, et al. Human papilloma-virus and oral cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003; 95:1772-1783.
25. Syrjanen S, Waterboer T, Sarkola M, et al. Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 2009; 90:1515-1526.
26. Templeton D, Jin F, Prestage G, et al. Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV negative homosexual men in Sydney, Australia. J Infect Dis 2009; 200:1813-1819.
27. Newall A, Brotherton J, Quinn H, et al. Population seropreva-lence of human papillomavirus types 6, 11, 16, and 18 in men, women and children in Australia. Clin Infect Dis 2008; 46:1647-1655.
28. Kreimer A, Alberg A, Viscidi R, et al. Gender differences in sexual biomarkers and behaviors associated with human papillo-mavirus-16,-18 and-33 seroprevalence. Sex Transm Dis 2004; 31:247-256.
29. Tobian A, Serwadda D, Quinn T, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309.
30. Gray R, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillo-mavirus in HIV-negative men: A randomized trial in Rakai, Uganda. J Infect Dis 2010; 201:1455-1462.